Core Laboratories (CLB) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Core Laboratories

NYSE•Energy•Oil & Gas Equipment & Services

$10.40-0.09(-0.01%)Pre-market

Market Cap

$467.37M

P/E

30.0x

P/S

0.9x

P/B

1.7x

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

How this company scores

AverageMetricSide Score: 48/100

Strongest: Balance Sheet & Red Flags (17/25); weakest: Growth (8/25).

Profitability11/25

Growth8/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality12/25

Strengths

Low leverageConsistent free cash flowImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 30.0x5y range 18.1x – 36.5x

Currently near its 11-quarter median.

P/S · 0.9x5y range 0.9x – 1.5x

Currently below its 11-quarter median.

P/B · 1.7x5y range 1.7x – 5.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 29.6% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -2.5x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $467.37M

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $516.74M
Q. Revenue: $132.08M
TTM EBITDA: $53.92M
TTM Op. Income: $38.94M
Q. Op. Income: $12.06M
TTM Net Income: $15.56M
Q. Net Income: $5.44M
EPS: $0.12
Shares Out.: $45.87M

$516.74M in TTM revenue declined 0.1% YoY, reaching $132.08M last quarter. TTM EBITDA of $53.92M and TTM operating income of $38.94M show growth is flowing through to the bottom line. TTM net income of $15.56M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 3 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 20.4%
EBITDA Margin: 12.0%
Op. Margin: 9.1%
Net Margin: 4.1%

Op. margin of 9.1% is down 6.4% YoY — costs are rising relative to revenue. Net margin at 4.1% and gross margin of 20.4% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 30.0x
P/S Ratio: 0.9x
P/B Ratio: 1.7x

At 30.0x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 0.9x and P/B of 1.7x provide additional context. P/E sits above typical market levels while revenue growth is below 5%. Over the past year, P/E is up 66% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $593.52M
Cash: $21.38M
Long-Term Debt: $112.45M
Book Value: $277.97M
D/E Ratio: 0.4
Debt/EBITDA: 7.1

With $593.52M in assets and $112.45M in long-term debt, D/E is 0.4and book value is $277.97M — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $4.97M
TTM Free Cash Flow: $10.36M
FCF Margin: 2.0%
FCF / Net Income: 0.7

TTM FCF of $10.36M on $4.97M in operating cash flow. The FCF / Net Income ratio of 0.7x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has fallen for 6 consecutive quarters — a weakening trend.